Company: NDRA
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001654954-25-012254
Chunk: 52

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 52
---
 cash will not be counted as issued shares for any purpose under the 2016 Plan. If any award expires, or is terminated, surrendered or forfeited, in whole or in part, the unissued shares covered by such award will again be available for the grant of awards. If shares issued pursuant to the 2016 Plan are repurchased by, or are surrendered or forfeited to the Company at no more than cost, such shares will again be available for the grant of awards. If shares issuable upon exercise, vesting or settlement of an award, or shares owned by a grantee (which are not subject to any pledge or other security interest), are surrendered or tendered to the Company in payment of the option price or purchase price of an award or any taxes required to be withheld in respect of an award, in each case, in accordance with the terms and conditions of the 2016 Plan and any applicable award agreement, such surrendered or tendered shares will again be available for the grant of awards. Substitute awards will not be counted against the number of shares available for the grant of awards.

Individual Award Limits

The maximum value of awards granted during any calendar year to any non-employee director, taken together with any cash fees paid to such non-employee director during the calendar year and the value of awards granted to the non-employee director under any other equity compensation plan of the Company or an affiliate during the calendar year, will not exceed the following in total value (calculating the value of any awards or other equity compensation plan awards based on the grant date fair value for financial reporting purposes): $300,000 for each non-employee director. Awards granted to non-employee directors upon their initial election to the Board or the board of directors of an affiliate will not be counted towards this limit.

Effective Date; Amendment and Termination

The 2016 Plan, as amended by the 2016 Plan Amendment, will become effective upon stockholder approval. The Board may, at any time and from time to time, amend, suspend or terminate the 2016 Plan as to any awards which have not been made. An amendment will be contingent on approval of the stockholders to the extent stated by the Board, required by applicable law or required by applicable securities exchange listing requirements. No awards will be made after the termination date of the 2016 Plan, which is scheduled to be November 14, 2026. The applicable terms of the 2016 Plan, and any terms and conditions applicable to awards granted prior to